1. Home
  2. BOLD vs ONMD Comparison

BOLD vs ONMD Comparison

Compare BOLD & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • ONMD
  • Stock Information
  • Founded
  • BOLD 2018
  • ONMD 2006
  • Country
  • BOLD United States
  • ONMD United States
  • Employees
  • BOLD N/A
  • ONMD N/A
  • Industry
  • BOLD
  • ONMD
  • Sector
  • BOLD
  • ONMD
  • Exchange
  • BOLD Nasdaq
  • ONMD Nasdaq
  • Market Cap
  • BOLD 24.4M
  • ONMD 22.2M
  • IPO Year
  • BOLD 2024
  • ONMD N/A
  • Fundamental
  • Price
  • BOLD $1.15
  • ONMD $0.84
  • Analyst Decision
  • BOLD Buy
  • ONMD
  • Analyst Count
  • BOLD 4
  • ONMD 0
  • Target Price
  • BOLD $4.00
  • ONMD N/A
  • AVG Volume (30 Days)
  • BOLD 79.9K
  • ONMD 3.3M
  • Earning Date
  • BOLD 11-06-2025
  • ONMD 08-13-2025
  • Dividend Yield
  • BOLD N/A
  • ONMD N/A
  • EPS Growth
  • BOLD N/A
  • ONMD N/A
  • EPS
  • BOLD N/A
  • ONMD N/A
  • Revenue
  • BOLD N/A
  • ONMD $459,000.00
  • Revenue This Year
  • BOLD N/A
  • ONMD N/A
  • Revenue Next Year
  • BOLD N/A
  • ONMD N/A
  • P/E Ratio
  • BOLD N/A
  • ONMD N/A
  • Revenue Growth
  • BOLD N/A
  • ONMD N/A
  • 52 Week Low
  • BOLD $1.00
  • ONMD $0.30
  • 52 Week High
  • BOLD $4.72
  • ONMD $1.56
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 49.88
  • ONMD 56.35
  • Support Level
  • BOLD $1.13
  • ONMD $0.82
  • Resistance Level
  • BOLD $1.16
  • ONMD $0.88
  • Average True Range (ATR)
  • BOLD 0.04
  • ONMD 0.09
  • MACD
  • BOLD 0.00
  • ONMD -0.00
  • Stochastic Oscillator
  • BOLD 62.50
  • ONMD 68.98

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.

Share on Social Networks: